CORRIGENDUM to ‘Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis’,Cephalalgia

当前位置： X-MOL 学术 › Cephalalgia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

CORRIGENDUM to ‘Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis’
Cephalalgia ( IF 4.9 ) Pub Date : 2021-09-14 , DOI: 10.1177/03331024211042798

Konstantina Drellia, Lili Kokoti, Christina I Deligianni, et al. Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis. Cephalalgia 2021; 41(7): 851–864. DOI: 10.1177/0333102421989601

中文翻译：

“用于预防偏头痛的抗 CGRP 单克隆抗体：系统评价和帮助或危害分析的可能性”的更正

Konstantina Drellia、Lili Kokoti、Christina I Deligianni 等。用于预防偏头痛的抗 CGRP 单克隆抗体：系统评价和帮助或危害分析的可能性。2021 年头痛；41（7）：851-864。DOI：10.1177/0333102421989601

更新日期：2021-09-15

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>